FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041066142> ?p ?o ?g. }

• W2041066142 endingPage "332" @default.
• W2041066142 startingPage "326" @default.
• W2041066142 abstract "<i>Background:</i> Unpredictable and severe diarrhea (NCI grade ≧3) remains a life-threatening adverse event in patients treated with irinotecan (CPT-11). The aim of this study was to evaluate the efficacy and safety of orally administered budesonide for prevention of CPT-11-induced delayed diarrhea in patients with advanced colorectal cancer. <i>Patients and Methods:</i> A total of 56 patients with advanced colorectal cancer receiving CPT-11 therapy (125 mg/m² once weekly) were enrolled in this multicenter trial. Patients were randomly treated with 3 mg budesonide orally 3 times daily versus placebo. Detailed assessment of diarrhea by monitoring stool frequency, stool consistency and loperamide rescue medication was made by keeping a diary. <i>Results:</i> Diarrhea, defined as number of stools >4 occurring on a single day during the study period, could be prevented in 58.3% of the budesonide-treated patients compared to 38.5% of the patients under placebo. Patients in the budesonide group had less episodes (0.7 vs. 2.2 episodes) and a considerably shorter total duration of diarrhea (1.8 vs. 4.2 days) episodes than patients in the placebo group. Loperamide use was more frequent in the placebo than in the budesonide arm (55.6 vs. 41.7%). Also, exposure to rescue medication of loperamide was higher for placebo (36.2 capsules) than for budesonide (24.9 capsules). A superior prevention of diarrhea was observed for budesonide compared to placebo in the first cycle (14 vs. 10; p = 0.257), with more failures observed in the placebo group (16 vs. 10). <i>Conclusion:</i> This double-blind randomized trial failed to show that budesonide has a significant benefit in preventing CPT-11-induced diarrhea. While a trend exists, further trials are warranted." @default.
• W2041066142 created "2016-06-24" @default.
• W2041066142 creator A5002333415 @default.
• W2041066142 creator A5009744765 @default.
• W2041066142 creator A5013772332 @default.
• W2041066142 creator A5032755056 @default.
• W2041066142 creator A5044929990 @default.
• W2041066142 creator A5048013654 @default.
• W2041066142 creator A5061190941 @default.
• W2041066142 creator A5064998125 @default.
• W2041066142 creator A5069585976 @default.
• W2041066142 creator A5077378669 @default.
• W2041066142 creator A5078417193 @default.
• W2041066142 creator A5090414010 @default.
• W2041066142 creator A5090917357 @default.
• W2041066142 creator A5026297032 @default.
• W2041066142 date "2005-01-01" @default.
• W2041066142 modified "2023-09-27" @default.
• W2041066142 title "Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer" @default.
• W2041066142 cites W135643801 @default.
• W2041066142 cites W1486430237 @default.
• W2041066142 cites W162882544 @default.
• W2041066142 cites W1832060645 @default.
• W2041066142 cites W1835830368 @default.
• W2041066142 cites W1869323251 @default.
• W2041066142 cites W1895902603 @default.
• W2041066142 cites W1989543921 @default.
• W2041066142 cites W1997014660 @default.
• W2041066142 cites W2027812459 @default.
• W2041066142 cites W2038765960 @default.
• W2041066142 cites W2089458297 @default.
• W2041066142 cites W2098822886 @default.
• W2041066142 cites W2102661337 @default.
• W2041066142 cites W2125942822 @default.
• W2041066142 cites W2128447158 @default.
• W2041066142 cites W2136955408 @default.
• W2041066142 cites W2157769714 @default.
• W2041066142 cites W2170902146 @default.
• W2041066142 cites W2199744731 @default.
• W2041066142 cites W2246394347 @default.
• W2041066142 cites W2272757036 @default.
• W2041066142 cites W2279052620 @default.
• W2041066142 cites W2314927739 @default.
• W2041066142 cites W2315072337 @default.
• W2041066142 cites W67218116 @default.
• W2041066142 doi "https://doi.org/10.1159/000086971" @default.
• W2041066142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16020959" @default.
• W2041066142 hasPublicationYear "2005" @default.
• W2041066142 type Work @default.
• W2041066142 sameAs 2041066142 @default.
• W2041066142 citedByCount "43" @default.
• W2041066142 countsByYear W20410661422012 @default.
• W2041066142 countsByYear W20410661422013 @default.
• W2041066142 countsByYear W20410661422014 @default.
• W2041066142 countsByYear W20410661422015 @default.
• W2041066142 countsByYear W20410661422016 @default.
• W2041066142 countsByYear W20410661422017 @default.
• W2041066142 countsByYear W20410661422018 @default.
• W2041066142 countsByYear W20410661422019 @default.
• W2041066142 countsByYear W20410661422020 @default.
• W2041066142 countsByYear W20410661422021 @default.
• W2041066142 countsByYear W20410661422022 @default.
• W2041066142 crossrefType "journal-article" @default.
• W2041066142 hasAuthorship W2041066142A5002333415 @default.
• W2041066142 hasAuthorship W2041066142A5009744765 @default.
• W2041066142 hasAuthorship W2041066142A5013772332 @default.
• W2041066142 hasAuthorship W2041066142A5026297032 @default.
• W2041066142 hasAuthorship W2041066142A5032755056 @default.
• W2041066142 hasAuthorship W2041066142A5044929990 @default.
• W2041066142 hasAuthorship W2041066142A5048013654 @default.
• W2041066142 hasAuthorship W2041066142A5061190941 @default.
• W2041066142 hasAuthorship W2041066142A5064998125 @default.
• W2041066142 hasAuthorship W2041066142A5069585976 @default.
• W2041066142 hasAuthorship W2041066142A5077378669 @default.
• W2041066142 hasAuthorship W2041066142A5078417193 @default.
• W2041066142 hasAuthorship W2041066142A5090414010 @default.
• W2041066142 hasAuthorship W2041066142A5090917357 @default.
• W2041066142 hasConcept C121608353 @default.
• W2041066142 hasConcept C126322002 @default.
• W2041066142 hasConcept C142724271 @default.
• W2041066142 hasConcept C197934379 @default.
• W2041066142 hasConcept C204787440 @default.
• W2041066142 hasConcept C27081682 @default.
• W2041066142 hasConcept C2776136866 @default.
• W2041066142 hasConcept C2776804153 @default.
• W2041066142 hasConcept C2777573665 @default.
• W2041066142 hasConcept C2779403890 @default.
• W2041066142 hasConcept C2779802037 @default.
• W2041066142 hasConcept C2780259306 @default.
• W2041066142 hasConcept C526805850 @default.
• W2041066142 hasConcept C71924100 @default.
• W2041066142 hasConcept C90924648 @default.
• W2041066142 hasConceptScore W2041066142C121608353 @default.
• W2041066142 hasConceptScore W2041066142C126322002 @default.
• W2041066142 hasConceptScore W2041066142C142724271 @default.
• W2041066142 hasConceptScore W2041066142C197934379 @default.
• W2041066142 hasConceptScore W2041066142C204787440 @default.
• W2041066142 hasConceptScore W2041066142C27081682 @default.

• next